Latest News

Warren Buffett keeps selling billions worth of stock in this frothy market — here are 3 new places where he’s finding value

0

Motley Fool

1 Cancer Stock on Buyout Watch in 2022

The pharmaceutical industry appears poised for a record-breaking level of merger and acquisition (M&A) activity in 2022. First, Pfizer (NYSE: PFE) and Moderna are both flush with cash thanks to their novel coronavirus vaccines. Third, Amgen, AstraZeneca, Biogen, Bristol Myers Squibb, Gilead Sciences, Johnson & Johnson, Merck, Moderna, Pfizer, and Sanofi are all expected to pursue bolt-on acquisitions next year to flesh out their clinical pipelines and product portfolios.

Read the emails Elon Musk sent Tesla employees about music on the job and following directions

Previous article

Trump Moneyman Patrick Orlando’s Wuhan SPAC Plans to Liquidate

Next article

You may also like

Comments

Leave a reply

Your email address will not be published.

More in Latest News